Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Total Current Liabilities: 2017-2024

Historic Total Current Liabilities for Solid Biosciences (SLDB) over the last 7 years, with Sep 2024 value amounting to $22.9 million.

  • Solid Biosciences' Total Current Liabilities rose 44.50% to $22.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $22.9 million, marking a year-over-year increase of 44.50%. This contributed to the annual value of $14.5 million for FY2023, which is 35.50% down from last year.
  • Per Solid Biosciences' latest filing, its Total Current Liabilities stood at $22.9 million for Q3 2024, which was up 55.60% from $14.7 million recorded in Q2 2024.
  • In the past 5 years, Solid Biosciences' Total Current Liabilities ranged from a high of $24.5 million in Q4 2020 and a low of $12.9 million during Q1 2020.
  • Moreover, its 3-year median value for Total Current Liabilities was $16.9 million (2022), whereas its average is $18.3 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 77.24% in 2021, then crashed by 35.50% in 2023.
  • Over the past 5 years, Solid Biosciences' Total Current Liabilities (Quarterly) stood at $24.5 million in 2020, then fell by 3.59% to $23.6 million in 2021, then declined by 4.63% to $22.5 million in 2022, then plummeted by 35.50% to $14.5 million in 2023, then soared by 44.50% to $22.9 million in 2024.
  • Its Total Current Liabilities was $22.9 million in Q3 2024, compared to $14.7 million in Q2 2024 and $14.3 million in Q1 2024.